Indication · GI, Urology & Nephrology
Liver disease and liver cancer
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
196
Cleared or approved since 2000
PMA and De Novo
28
Higher-risk or first-of-kind devices
Breakthrough devices
4
Authorized through June 30, 2026
Recruiting device trials
82
693 device trials in all
Breakthrough-designated devices
- LIAISON® XL MUREX Anti-HDV (318260)DiaSorin, Inc. · 2025
- alfapump SystemSequana Medical NV · 2024
- Edison SystemHistoSonics, Inc. · 2024
1 more devices with a free account
Devices
196 devices. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- OrganOx metra® System
Organox Limited · PMA · Normothermic Machine Perfusion System For The Preservation Of Donor Livers Prior To Transplantation · newest 2026 · 16 decisions
- TheraSphere
Boston Scientific Corporation · PMA · Microspheres Radionuclide · newest 2026 · 7 decisions
- Organ Care System (OCS) Liver
TransMedics, Inc. · PMA · Normothermic Machine Perfusion System For The Preservation Of Donor Livers Prior To Transplantation · newest 2026 · 5 decisions
57 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
Sun Yat-sen UniversityAcademic, hospital or other
NCT07947342 · 43 participants (planned) · Start Oct 20, 2026 · Primary completion Oct 2028
Device: Blank microspheres · For: Hepatocellular Carcinoma; Liver Neoplasms
Sites: Guangzhou, China
- The Vanguard Study: Testing a New Way to Screen for CancerPivotal-lookingRecruiting
National Cancer Institute (NCI)NIH
NCT06995898 · 24,000 participants (planned) · Start Jun 18, 2025 · Primary completion Jan 31, 2029
Device: Device Usage · For: Bladder Carcinoma; Breast Carcinoma; Colorectal Carcinoma and 8 more
Sites: Pleasanton, California; San Diego, California; Cheyenne Wells, Colorado · 49 sites in all
- Analysis of Breath Volatile Organic Compounds Using Mass SpectrometryNot yet recruiting
University of OklahomaAcademic, hospital or other
NCT07732686 · 2,000 participants (planned) · Start Nov 2026 · Primary completion Nov 2027
Device: Proton Transfer Reaction Mass Spectrometry Analysis · For: Pancreas Cancer; Hepatocellular Carcinoma; Lung Cancer and 6 more
Sites: Oklahoma City, Oklahoma
690 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Diazo Colorimetry, Bilirubin (CIG)38
- Hepatitis A Test (Antibody And Igm Antibody) (LOL)24
- Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes (CJE)22
- Peritoneal, Drainage Catheter For Refractory Ascites, Long-Term Indwelling (PNG)11
- Nadh Oxidation/Nad Reduction, Ast/Sgot (CIT)10
- Enzymatic Method, Ammonia (JIF)9
- Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control (DBM)8
- Enzymatic Method, Bilirubin (JFM)8
- Radiological Image Processing Software For Ablation Therapy Planning And Evaluation (QTZ)7
- Shunt, Peritoneal (KPM)6
- Shunt, Portosystemic, Endoprosthesis (MIR)6
- Nadh Oxidation/Nad Reduction, Alt/Sgpt (CKA)4
- Tracking, Soft Tissue, Intraoperative (OEW)4
- Microspheres Radionuclide (NAW)3
- Autoantibodies, Lkm-1 (Liver/Kidney Microsome, Type 1) (NBS)3
- Autoantibodies, Anti-Soluble Liver Antigen (Sla), Autoimmune Hepatitis (NIY)3
- Liver Iron Concentration Imaging Companion Diagnostic For Deferasirox (PCS)3
- Apparatus, Hemoperfusion, Sorbent (FLD)2
- Radioimmunoassay, Cholyglycine, Bile Acids (KWW)2
- Autoantibodies, Nuclear Pore Glycoprotein Gp210 (NRI)2
- Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment (NSF)2
- Normothermic Machine Perfusion System For The Preservation Of Donor Livers Prior To Transplantation (QQK)2
- Post-Ablation Tissue Response Prediction Software (QZL)2
- Hydrazone Colorimetry, Ast/Sgot (CIS)1
- Indirect Copper Assay, Ceruloplasmin (JFR)1
- Photometric Method, Ammonia (JID)1
- Colorimetric Method, Gamma-Glutamyl Transpeptidase (JPZ)1
- Radioimmunoassay, Conjugated Sulfalithocholic (Slcg) Acid, Bile Acids (KWX)1
- Antibodies, Anti-Actin, Anti-Smooth Muscle (NJF)1
- Autoantibodies, Nuclear Body Protein, Sp100 (NUM)1
Research
- Device studies on liver cirrhosis across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.